Conference Coverage

Liver transplantation is on the rise for patients with severe alcoholic hepatitis


 

REPORTING FROM DDW


Another compounding issue was that patients were not counseled on their alcohol consumption habits, leading to further issues with transplantation. “Not infrequently, patients receive a diagnosis of severe alcoholic hepatitis during their initial visit and no one had previously told them to stop drinking. Since their presentation was preceded by active alcohol consumption, they would essentially be rendered ineligible for a transplant at that time,” she said.

Despite the history surrounding liver transplants in patients with severe alcoholic hepatitis, Dr. Bangaru hopes the shift in practice will improve the lives of more patients. “Because this practice of transplantation is being increasingly accepted and demonstrating positive outcomes, the hope is that more patients will be evaluated for transplantation and that transplant centers will improve their posttransplant support to ensure patients have great success after transplantation.”

Digestive Disease Week® is jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy (ASGE), and the Society for Surgery of the Alimentary Tract (SSAT).

Pages

Recommended Reading

Heavy drinking did not worsen clinical outcomes from drug-induced liver injury
MDedge Internal Medicine
Alpha fetoprotein boosted detection of early-stage liver cancer
MDedge Internal Medicine
DAAs open up organ donation from HCV patients
MDedge Internal Medicine
Hep B therapy: Indefinite or FINITE for e-negative patients?
MDedge Internal Medicine
New options emerge for primary biliary cholangitis
MDedge Internal Medicine
Treatment of HCV in special populations
MDedge Internal Medicine
New drugs provide new options in HCC
MDedge Internal Medicine
Class III obesity increases risk of acute on chronic liver failure in cirrhotic patients
MDedge Internal Medicine
Where the latest HCV drug combos fit in
MDedge Internal Medicine
How to choose between highly effective HBV therapies
MDedge Internal Medicine